The present disclosure relates to combinations of compounds comprising HIVintegrase inhibitors and other therapeutic agents. Such combinations may beuseful inthe inhibition of HIV-1 or potentially the inhibition of HIV replication, orfor the preventionand/or treatment of infection by HIV, or in the treatment of AIDS and/or ARC.